Uncategorized
Uncategorized · page 4
- Uncategorized
Key Insights from Mary Jane Berlin x Business of Cannabis’ Inaugural B2B Day
European Cannabis Week 2025 has officially begun, seeing thousands of Europe’s cannabis thought leaders, innovators and decision makers descend on Berlin’s vast Messe Berlin for the first day of Mary Jane Berlin.
- Uncategorized
Congress Amends Language of Potential Hemp-Killing Bill, But Industry Warns Non-Intoxicating Hemp Still Under Existential Threat
The ongoing battle to rescue the US hemp industry has reached boiling point, as the 2026 spending bill continues to advance.
- Uncategorized
Aurora Cannabis Faces Class Action Over Lack of Warnings About Cannabinoid Hyperemesis Syndrome
A national class action has been brought against Aurora Cannabis in Canada, alleging that the company ‘negligently’ failed to warn consumers about the risk of developing Cannabinoid Hyperemesis Syndrome (CHS).
- Uncategorized
Court Ruling Against German Online Cannabis Clinic Signals Looming Crackdown
Germany tightens control on online cannabis prescriptions. Court ruling bans advertising, while Health Minister calls for stricter access to medical cannabis via online platforms.
- Uncategorized
Cost vs Care: Can Clinics Stay Affordable While Scaling Responsibly?
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
- Uncategorized
Countdown to Cannabis Europa London 2025: Celebrating Our Pioneering Sponsors
We are proud to be supported by some of the cannabis industry’s most forward-thinking and influential businesses. Their backing helps create an environment where innovation thrives, meaningful connections are made, and bold ideas can take shape.
- Uncategorized
US Spending Bill Takes Aim at Cannabis Rescheduling Project
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
- Uncategorized
EU Moves to Improve Conditions for Embattled Biotech Sector, Ananda’s Clinical Development Pushes On, & Celadon Remains on the Brink
In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as part of ongoing efforts by the European Commission to strengthen the continent’s biotechnology and biomanufacturing sectors, which have struggled with fragmented rules and sluggish approval processes.
- Uncategorized
Much-Needed Or More Delays? UK Industry Responds to Upcoming ACMD Review of Cannabis-Based Medicines
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
- Uncategorized
Is the Golden Era of Thca Flower Coming to an End?
Steven Brown firmly believes THCA flower is federally legal hemp under the 2018 Farm Bill.
- Uncategorized
MediPharm On the Brink: Shareholder Revolt Reaches Boiling Point as Board Fight for Survival at Canandian Cannabis Giant
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital moves to unseat the entire board amid allegations of financial misconduct, mismanagement, and self-enrichment.
- Uncategorized
‘It’s Disneyland for Cannabis’: Mary Jane Berlin Founder on Taking the Grassroots Festival to New Heights
Ahead of Mary Jane Berlin, which returns later this month as part of European Cannabis Week, CEO Duc Anh Dang, spoke to Business of Cannabis about taking the festival to the next level and learning lessons along the way.
